Literature DB >> 29150272

Proposed biochemistry of Parkinson's and Alzheimer's diseases.

D S Robertson1.   

Abstract

The formation of brain compounds linked to Parkinson's and Alzheimer's brain diseases are described. Metabolic mechanisms involved in the control of reacting biochemicals are detailed. Relationships are established between the biochemical reactions, biochemical control mechanisms and the onset of Parkinson's, Alzheimer's. Treatments based on these relationships are proposed.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Betaines; Monatomic oxygen; Parkinson’s disease

Mesh：

Substances：

Year:  2017        PMID： 29150272     DOI： 10.1016/j.mehy.2017.08.013

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN： 0306-9877            Impact factor:   1.538


  3 in total

1.  Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35.

Authors:  Mengying Wei; Yuanyuan Liu; Zifeng Pi; Kexin Yue; Shizhe Li; Mingxin Hu; Zhiqiang Liu; Fengrui Song; Zhongying Liu
Journal:  RSC Adv       Date:  2019-06-10       Impact factor: 4.036

2.  T1-weighted MRI-driven Brain Age Estimation in Alzheimer's Disease and Parkinson's Disease.

Authors:  Iman Beheshti; Shiwangi Mishra; Daichi Sone; Pritee Khanna; Hiroshi Matsuda
Journal:  Aging Dis       Date:  2020-05-09       Impact factor: 6.745

3.  Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease.

Authors:  Wenhao Wu; Xintong Liang; Guoquan Xie; Langdi Chen; Weixiong Liu; Guolin Luo; Peiquan Zhang; Lihong Yu; Xuehua Zheng; Hong Ji; Chao Zhang; Wei Yi
Journal:  Molecules       Date:  2018-10-05       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.